Company intelligence / Profile preview

Iheoo Healthcare Advisory

Beijing, Beijing, China

Ownership: Private
Development stage: Other

Overview

IHEOO is a specialized healthcare advisory firm based in China, providing strategic consulting services to the pharmaceutical, biotechnology, and medical device industries. The company focuses on market access, pricing and reimbursement strategies, and commercialization support within the Chinese healthcare landscape. IHEOO leverages deep industry expertise and data-driven insights to help global and domestic clients navigate complex regulatory environments and optimize product launches. Their services include policy analysis, health economics and outcomes research (HEOR), and strategic planning for market entry. The firm is particularly noted for its expertise in navigating the National Reimbursement Drug List (NRDL) negotiations.

Industry: Consulting

Beyond the preview

Go deeper on Iheoo Healthcare Advisory.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Iheoo Healthcare Advisory.

Explore the full profile